Featured Research

from universities, journals, and other organizations

Kidney Function Discovery Sheds Light On Genetic Complexity Of Disease

Date:
December 1, 2008
Source:
Centenary Institute
Summary:
To find a cure for cancer, hemophilia and other diseases, researchers need to be looking for complex, interacting genetic factors, according to the authors of a new study.

To find a cure for cancer, haemophilia and other diseases, researchers need to be looking for complex, interacting genetic factors, according to the authors of a new study.

A new study by researchers at the Centenary Institute, Royal Prince Alfred Hospital (RPA) and The Australian National University (ANU), has exposed a greater level of genetic complexity for diseases than was originally thought.

The researchers looked at two disorders of kidney function - iminoglycinuria and hyperglycinuria. These disorders, first described 50 years ago, are conditions where large amounts of individual amino acids (the building blocks of proteins in our body) are wasted by the kidney.

Professor John Rasko, Head, Gene and Stem Cell Therapy program at Centenary Institute and Cell and Molecular Therapies at RPA, says although up to one in every thousand babies has this disorder at birth, it usually resolves in the first year of life. For those individuals in whom it continues to occur, it is generally thought not to cause medical problems but previous cases have been linked to high blood pressure, kidney stones, deafness and problems in the brain.

"Iminoglycinuria was observed to occur in families and the pattern of inheritance suggested that the cause might be due to an inherited abnormality of a specific pump on the surface of kidney cells," Professor Rasko explains.

The teams from Centenary Institute, RPA and ANU have now unravelled the genetic explanation by showing that not one, but up to four different pumps present in the kidney determine whether or not this particular abnormality occurs.

"The study demonstrates that in some cases mutations occur only in one gene, while in other cases mutations in two or even three different genes are observed, and that the disorders can arise due to mutations in a group of genes carrying out related functions," says Professor Stefan Broer, School of Biochemistry and Molecular Biology at ANU.

"From the point of view of understanding complex diseases in humans, it suggests we need to integrate much greater levels of complex genetic information to reach a clear understanding."

Professor Rasko says that these findings provide a foundation to improve our understanding of common human diseases, and greater potential to develop effective gene therapies to reduce the impact of diseases on patients.

"Gene therapies, whereby cells can be modified and then re-introduced into the body without the genetic mutations that cause illness, provide enormous potential to help cure diseases including haemophilia, cancer and cardiovascular disease," Professor Rasko explains.

"A crucial ingredient of successfully developing gene therapies is a thorough understanding of all the genetic factors at play in disease. This discovery takes us one step closer to understanding the complex factors at work in these serious diseases."

Financial support was provided by the National Health and Medical Research Council (project grant 402730), the Australian Research Council (Discovery Project DP0877897), the Private Practice Fund at The Canberra Hospital, the Rebecca L. Cooper Foundation, and The Cell and Gene Trust.


Story Source:

The above story is based on materials provided by Centenary Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Brφer, S, Bailey CB, Kowalczuk, S, Ng, C, Vanslambrouck, JM, Rodgers, H, Auray-Blais, C, Cavanaugh, JA, Brφer, A and Rasko JEJ. minoglycinuria and hyperglycinuria are discrete phenotypes explained by complex mutations in proline and glycine transporters. Journal of Clinical Investigation, Online November 25, 2008; December print issue

Cite This Page:

Centenary Institute. "Kidney Function Discovery Sheds Light On Genetic Complexity Of Disease." ScienceDaily. ScienceDaily, 1 December 2008. <www.sciencedaily.com/releases/2008/11/081126091543.htm>.
Centenary Institute. (2008, December 1). Kidney Function Discovery Sheds Light On Genetic Complexity Of Disease. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/11/081126091543.htm
Centenary Institute. "Kidney Function Discovery Sheds Light On Genetic Complexity Of Disease." ScienceDaily. www.sciencedaily.com/releases/2008/11/081126091543.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins